TRDA ENTRADA THERAPEUTICS INC
2026Q1 · CUSIP 29384C108 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
118
Δ holders QoQ
+5
Breadth percentile
Top 43%
Whale holders
68
Δ whales
+2
Inst. holding value
$321M
New positions
20
Closed positions
15
Price momentum (1Q)
-46.6%
Put / Call
0/1
Breadth history (34 quarters)
Past Lit Events & Aftermath 1 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2024Q1 | Top 19% | +10.2% | +19.1% |
Options Sentiment
Put holders
0
QoQ: -1
Call holders
1
QoQ: 0
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-4.00
EPS YoY
-789.7%
Revenue (TTM)
$0.0B
Revenue YoY
-96.7%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)